Cardiovascular and renal efficacy and safety of sodium-glucose cotransporter-2 inhibitors in patients without diabetes: a systematic review and meta-analysis of randomised placebo-controlled trials.
Wan-Chuan TsaiShih-Ping HsuYen-Ling ChiuJu-Yeh YangMei-Fen PaiMei-Ju KoYu-Kang TuKuan-Yu HungKuo Liong ChienYu-Sen PengHon-Yen WuPublished in: BMJ open (2022)
CRD42021239807.
Keyphrases
- placebo controlled
- end stage renal disease
- double blind
- clinical trial
- ejection fraction
- type diabetes
- newly diagnosed
- cardiovascular disease
- study protocol
- prognostic factors
- peritoneal dialysis
- open label
- randomized controlled trial
- squamous cell carcinoma
- metabolic syndrome
- patient reported outcomes
- radiation therapy
- phase iii